BioMarin Pharmaceutical Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BMRN Nasdaq 2830 www.biomarin.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioMarin Pharmaceutical Inc.

BioMarin (BMRN) Q3 2026 Earnings Call Transcript - Nov 2nd, 2026 9:43 pm
BioMarin Pharmaceutical Q3 Earnings Call Highlights - Nov 2nd, 2026 7:14 pm
BioMarin Pharmaceutical (BMRN) Could Be 21% Undervalued On Mixed Q3 Guidance Cut - Nov 2nd, 2026 7:09 pm
BioMarin (BMRN) Stock May Be A Bargain After Fabry Therapy Deal - Nov 2nd, 2026 6:24 pm
BioMarin: Q3 Earnings Snapshot - Nov 2nd, 2026 4:01 pm
BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Nov 2nd, 2026 3:00 pm
BioMarin Pharmaceutical (BMRN) Q3 Earnings Surpass Estimates - Nov 2nd, 2026 2:55 pm
BioMarin Pharmaceutical (NASDAQ:BMRN) reports Q3 2026 in line with expectations but full-year sales guidance misses expectations - Nov 2nd, 2026 2:25 pm
BioMarin Reports Third Quarter 2026 Financial and Operating Results - Nov 2nd, 2026 2:03 pm
BioMarin Pharmaceutical (BMRN) Q3 earnings: what to expect - Nov 1st, 2026 3:40 pm
AnaptysBio (ANAB) vs. PTCT and MIRM: Is the Market Missing the Value of Its Royalty Stream and Legal Upside? - Oct 31st, 2026 3:17 pm
Stocktwits Biotech Dealmaker: BioMarin’s Fabry Disease Drug Candidate License Dominates Slow Week In Dealmaking - Oct 30th, 2026 6:20 pm
Exelixis (EXEL) vs. BMRN and NBIX: Can CABOMETYX and Pipeline Growth Revive Investor Confidence? - Oct 29th, 2026 11:18 am
BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease - Oct 29th, 2026 6:45 am
What Would Slower New Drug Sales Do To Vertex Stock? - Oct 28th, 2026 6:01 am
BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4:30pm ET - Oct 26th, 2026 7:00 am
Vertex Stock Looks Expensive. Does It Get Cheaper Ahead? - Oct 23rd, 2026 11:29 am
Earnings Preview: Bristol Myers Squibb (BMY) Q3 Earnings Expected to Decline - Oct 22nd, 2026 7:00 am
Why Should You Think About Vertex Differently Now? - Oct 20th, 2026 6:56 pm
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy? - Oct 19th, 2026 7:00 am